These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3517541)

  • 1. Cell agglutination by a novel cell surface sialoglycopeptide inhibitor and the relationship between its protease and biological activities.
    Sobieski RJ; Johnson TC; Sharifi BG; Bascom CC
    Life Sci; 1986 May; 38(20):1883-8. PubMed ID: 3517541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between protease activity and a sialoglycopeptide inhibitor isolated from bovine brain.
    Sharifi BG; Bascom CC; Fattaey H; Nash S; Johnson TC
    J Cell Biochem; 1986; 31(1):41-57. PubMed ID: 3522610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of a calcium and a sodium ionophore on protein synthesis inhibition by a bovine cell surface sialoglycopeptide.
    Sharifi BG; Bascom CC; Johnson TC
    Biochem Biophys Res Commun; 1986 May; 136(3):976-82. PubMed ID: 3087351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell surface interaction is sufficient for the biological activity of a bovine sialoglycopeptide inhibitor.
    Sharifi BG; Bascom CC; Johnson TC
    Biochem Biophys Res Commun; 1986 Feb; 134(3):1350-7. PubMed ID: 3947369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor occupancy by a bovine sialoglycopeptide inhibitor correlates with inhibition of protein synthesis.
    Bascom CC; Sharifi BG; Johnson TC
    J Cell Physiol; 1986 Aug; 128(2):202-8. PubMed ID: 3733887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of a bovine cerebral cortex cell surface sialoglycopeptide that inhibits cell proliferation and metabolism.
    Sharifi BG; Johnson TC; Khurana VK; Bascom CC; Fleenor TJ; Chou HH
    J Neurochem; 1986 Feb; 46(2):461-9. PubMed ID: 2416876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of epidermal growth factor-stimulated DNA synthesis by a bovine sialoglycopeptide inhibitor occurs at an intracellular level.
    Bascom CC; Sharifi BG; Johnson TC
    J Cell Biochem; 1987 Aug; 34(4):283-91. PubMed ID: 3497936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and stability characterization of a cell regulatory sialoglycopeptide inhibitor.
    Moos PJ; Fattaey HK; Johnson TC
    J Cell Biochem; 1995 Sep; 59(1):79-90. PubMed ID: 8530539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle arrest and cellular differentiation mediated by a cell surface sialoglycopeptide.
    Edson GD; Fattaey HK; Johnson TC
    Life Sci; 1991; 48(19):1813-20. PubMed ID: 2041455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of cell-surface glycopeptides from bovine cerebral cortex that inhibit cell growth and protein synthesis in normal but not in transformed cells.
    Kinders RJ; Johnson TC
    Biochem J; 1982 Sep; 206(3):527-34. PubMed ID: 7150260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the retinoblastoma protein in cell cycle arrest mediated by a novel cell surface proliferation inhibitor.
    Enebo DJ; Fattaey HK; Moos PJ; Johnson TC
    J Cell Biochem; 1994 Jun; 55(2):200-8. PubMed ID: 8089195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The identification of a naturally occurring cell surface growth inhibitor related to a previously described bovine sialoglycopeptide.
    Fattaey HK; Enebo DJ; Moos PJ; Johnson TC
    J Cell Biochem; 1993 May; 52(1):69-77. PubMed ID: 8320276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle dependent agglutinability, distribution of concanavalin A binding sites and surface morphology of normal and transformed fibroblasts.
    Collard JG; Temmink JH
    Adv Exp Med Biol; 1975; 55():221-44. PubMed ID: 168744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concanavalin A as a quantitative and ultrastructural probe for normal and neoplastic cell surfaces.
    Nicolson GL
    Adv Exp Med Biol; 1975; 55():153-72. PubMed ID: 168743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcolectin: an interferon antagonist extracted from hamster sarcomas and normal muscles. Isolation, characterization, and purification.
    Jiang PH; Chany-Fournier F; Robert-Galliot B; Sarragne M; Chany C
    J Biol Chem; 1983 Oct; 258(20):12361-7. PubMed ID: 6195152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface changes in transformed cells detected by lectins.
    Burger MM
    Fed Proc; 1973 Jan; 32(1):91-101. PubMed ID: 4346328
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of DNA synthesis and cell division by a cell surface sialoglycopeptide.
    Fattaey H; Johnson TC; Chou HH
    J Cell Physiol; 1989 May; 139(2):269-74. PubMed ID: 2715187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a sialoglycopeptide on early events associated with signal transduction.
    Toole-Simms WE; Loder DK; Fattaey HK; Johnson TC
    J Cell Physiol; 1991 May; 147(2):292-7. PubMed ID: 2040660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of local anesthetics on membrane properties. II. Enhancement of the susceptibility of mammalian cells to agglutination by plant lectins.
    Poste G; Papahadjopoulos D; Jacobson K; Vail WJ
    Biochim Biophys Acta; 1975 Jul; 394(4):520-39. PubMed ID: 167839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of bovine factor VIII with human platelets.
    Kirby EP; Mills DC
    J Clin Invest; 1975 Aug; 56(2):491-502. PubMed ID: 807600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.